SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-015215
Filing Date
2021-08-03
Accepted
2021-08-02 19:01:34
Documents
14
Period of Report
2021-07-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20210729.htm   iXBRL 8-K 38703
6 ardx-20210729_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-21-015215.txt   222199

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20210729.xsd EX-101.SCH 2153
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20210729_def.xml EX-101.DEF 15312
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20210729_lab.xml EX-101.LAB 29720
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20210729_pre.xml EX-101.PRE 15969
7 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20210729_htm.xml XML 13464
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 211137333
SIC: 2834 Pharmaceutical Preparations